CVE-2021-31833
Potential product security bypass vulnerability in McAfee Application and Change Control (MACC)...
Potential product security bypass vulnerability in McAfee Application and Change Control (MACC) prior to version 8.3.4 allows a locally logged in attacker to circumvent the application solidification protection provided by MACC, permitting them to run applications that would usually be prevented by MACC. This would require the attacker to rename the specified binary to match name of any configured updater and perform a specific set of steps, resulting in the renamed binary to be to run.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- None
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
Potential product security bypass vulnerability in McAfee Application and Change Control (MACC) prior to version 8.3.4 allows a locally logged in attacker to circumvent the application solidification protection provided by MACC, permitting them to run applications that would usually be prevented by MACC. This would require the attacker to rename the specified binary to match name of any configured updater and perform a specific set of steps, resulting in the renamed binary to be to run.
- Record
CVE-2021-31833- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H - Weakness
- CWE-269
- Updated
- 2026-11-02
EUVDEUVD-2021-18708
Potential product security bypass vulnerability in McAfee Application and Change Control (MACC) prior to version 8.3.4 allows a locally logged in attacker to circumvent the application solidification protection provided by MACC, permitting them to run applications that would usually be prevented by MACC. This would require the attacker to rename the specified binary to match name of any configured updater and perform a specific set of steps, resulting in the renamed binary to be to run.
- Record
EUVD-2021-18708- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-vm64-pmpq-wg92
Potential product security bypass vulnerability in McAfee Application and Change Control (MACC)...
Potential product security bypass vulnerability in McAfee Application and Change Control (MACC) prior to version 8.3.4 allows a locally logged in attacker to circumvent the application solidification protection provided by MACC, permitting them to run applications that would usually be prevented by MACC. This would require the attacker to rename the specified binary to match name of any configured updater and perform a specific set of steps, resulting in the renamed binary to be to run.
- Record
GHSA-vm64-pmpq-wg92- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-269
- Updated
- 2026-11-02
NVD
Potential product security bypass vulnerability in McAfee Application and Change Control (MACC) prior to version 8.3.4 allows a locally logged in attacker to circumvent the application solidification protection provided by MACC, permitting them to run applications that would usually be prevented by MACC. This would require the attacker to rename the specified binary to match name of any configured updater and perform a specific set of steps, resulting in the renamed binary to be to run.
- Record
CVE-2021-31833- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H - CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 4.6 Medium
AV:L/AC:L/Au:N/C:P/I:P/A:P - Weakness
- CWE-269
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2021-31833 is a high vulnerability (CVSS 7.1) in Mcafee Application And Change Control, published January 4, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.26%, the 17th percentile. No source names a fixed version.